Abstract:Key PointsAlthough for a long time necrosis was considered to be a purely accidental cell death subroutine, multiple lines of evidence now show that necrotic cell death can be regulated, both in its occurrence and in its course. The term 'necroptosis' was introduced by Yuan's research group in 2005 to indicate 'programmed' (as opposed to 'accidental') necrosis.The best characterized signal transduction cascade leading to necroptosis is initiated by ligand-bound tumour necrosis factor (TNF) receptor 1 (TNFR1), which allows for the assembly of a cytoplasmic supramolecular complex — TNFR complex I — that includes (among other proteins) TNFR-associated death domain (TRADD), cellular inhibitor of apoptosis 1 (cIAP1), cIAP2 and receptor-interacting protein kinase 1 (RIP1; also known as RIPK1).In complex I, RIP1 can be ubiquitylated by cIAPs and deubiquitylated by cylindromatosis (CYLD) and A20 (also known as TNFAIP3). Whereas ubiquitylated RIP1 promotes the activation of the nuclear factor κB (NF-κB) system, deubiquitylated RIP1 functions as a cell death-inducing kinase.On TNFR1 internalization, the so-called TNFR complex II is formed, which contains TRADD, FAS-associated protein with a death domain (FADD) and caspase 8. Normally, caspase 8 becomes activated in complex II, thereby igniting a pro-apoptotic caspase cascade. When caspase activation is prevented, however, RIP1 physically and functionally interacts with RIP3 (also known as RIPK3), thereby generating a necroptosis-inducing complex known as the necrosome.Necroptosis can also be ignited by pathogen recognition receptors, including Toll-like receptors, NOD-like receptors and retinoic acid-inducible gene I-like receptors, as well as in response to DNA damage, presumably by a poly(ADP-ribose) polymerase-1 (PARP1)-dependent signalling pathway.Although the underlying molecular mechanisms remain obscure, reactive oxygen species (ROS), bioenergetic metabolic cascades and the release of cytotoxic factors from lysosomes and mitochondria all contribute to the execution of necroptosis.Regulated necrosis has been seen in multiple, evolutionarily distant model organisms, including yeast, nematodes, fruit flies, rodents, primates and human cells, corroborating the notion that necroptosis may represent a phylogenetically conserved mechanism for programmed cell death.Numerous in vivo studies indicate that the inhibition of necroptosis (by genetic means or by RIP1-targeting agents called necrostatins) can confer consistent cytoprotection, suggesting that necroptosis may constitute a promising target for drug development.

Programmed cell death as a defence against infection

Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (Panoptosis)

Pyroptosis in defense against intracellular bacteria

Molecular mechanism of pyroptosis and inflammasome activation

Emerging connectivity of programmed cell death pathways and its physiological implications

Programmed Necrosis: Backup to and Competitor with Apoptosis in the Immune System

Control of Cell Death in Health and Disease

Plasma Membrane Pores Drive Inflammatory Cell Death

Pyroptosis-Induced Inflammation and Tissue Damage

Using Small Molecules to Dissect Non‐apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis

Programmed Cell Death in the Evolutionary Race against Bacterial Virulence Factors.

Molecular mechanisms of necroptosis: an ordered cellular explosion

Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection

Physiological Consequences of Programmed Necrosis, an Alternative Form of Cell Demise

Plasma membrane changes during programmed cell deaths

Pyroptosis in host defence against bacterial infection

Overview of necroptosis and pyroptosis signaling pathways

Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections

Programmed necrosis in the cross talk of cell death and inflammation.

Focus on the Mechanisms and Functions of Pyroptosis, Inflammasomes, and Inflammatory Caspases in Infectious Diseases

The molecular regulation of programmed necrotic cell injury